303 related articles for article (PubMed ID: 17616393)
21. HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism.
Subbaramaiah K; Howe LR; Port ER; Brogi E; Fishman J; Liu CH; Hla T; Hudis C; Dannenberg AJ
Cancer Res; 2006 May; 66(10):5504-11. PubMed ID: 16707480
[TBL] [Abstract][Full Text] [Related]
22. Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
Knower KC; To SQ; Takagi K; Miki Y; Sasano H; Simpson ER; Clyne CD
Breast Cancer Res Treat; 2012 Apr; 132(2):765-71. PubMed ID: 22237979
[TBL] [Abstract][Full Text] [Related]
23. Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms.
Hardy DB; Janowski BA; Chen CC; Mendelson CR
Mol Endocrinol; 2008 Aug; 22(8):1812-24. PubMed ID: 18483177
[TBL] [Abstract][Full Text] [Related]
24. The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells.
Wang Y; Lee KW; Chan FL; Chen S; Leung LK
Toxicol Sci; 2006 Jul; 92(1):71-7. PubMed ID: 16611627
[TBL] [Abstract][Full Text] [Related]
25. Leptin induces CREB-dependent aromatase activation through COX-2 expression in breast cancer cells.
Kim HG; Jin SW; Kim YA; Khanal T; Lee GH; Kim SJ; Rhee SD; Chung YC; Hwang YJ; Jeong TC; Jeong HG
Food Chem Toxicol; 2017 Aug; 106(Pt A):232-241. PubMed ID: 28571770
[TBL] [Abstract][Full Text] [Related]
26. Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells.
Park SY; Kim YH; Kim Y; Lee SJ
J Cell Biochem; 2012 Dec; 113(12):3653-62. PubMed ID: 22740037
[TBL] [Abstract][Full Text] [Related]
27. Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E₂ production in human endometriotic stromal cells in spheroid culture.
Yamanaka K; Xu B; Suganuma I; Kusuki I; Mita S; Shimizu Y; Mizuguchi K; Kitawaki J
Fertil Steril; 2012 Feb; 97(2):477-82. PubMed ID: 22130322
[TBL] [Abstract][Full Text] [Related]
28. Aromatase and breast cancer.
Chen S
Front Biosci; 1998 Aug; 3():d922-33. PubMed ID: 9696881
[TBL] [Abstract][Full Text] [Related]
29. Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents.
Brueggemeier RW; Richards JA; Joomprabutra S; Bhat AS; Whetstone JL
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):75-84. PubMed ID: 11850210
[TBL] [Abstract][Full Text] [Related]
30. Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF-alpha, IL-6 and COX-2 mRNAs in human breast cancer.
Irahara N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Int J Cancer; 2006 Apr; 118(8):1915-21. PubMed ID: 16287071
[TBL] [Abstract][Full Text] [Related]
31. Lead optimization of 7-benzyloxy 2-(4'-pyridylmethyl)thio isoflavone aromatase inhibitors.
Su B; Hackett JC; Díaz-Cruz ES; Kim YW; Brueggemeier RW
Bioorg Med Chem; 2005 Dec; 13(23):6571-7. PubMed ID: 16125392
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of intratumoral aromatase messenger RNA levels by docetaxel in human breast cancers.
Miyoshi Y; Kim SJ; Akazawa K; Kamigaki S; Ueda S; Yanagisawa T; Inoue T; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2004 Dec; 10(24):8163-9. PubMed ID: 15623590
[TBL] [Abstract][Full Text] [Related]
33. A positive feedback pathway of estrogen biosynthesis in breast cancer cells is contained by resveratrol.
Wang Y; Ye L; Leung LK
Toxicology; 2008 Jun; 248(2-3):130-5. PubMed ID: 18462857
[TBL] [Abstract][Full Text] [Related]
34. Regulation of breast cancer-associated aromatase promoters.
Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
[TBL] [Abstract][Full Text] [Related]
35. BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.
Lu M; Chen D; Lin Z; Reierstad S; Trauernicht AM; Boyer TG; Bulun SE
J Clin Endocrinol Metab; 2006 Nov; 91(11):4514-9. PubMed ID: 16940443
[TBL] [Abstract][Full Text] [Related]
36. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H
Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110
[TBL] [Abstract][Full Text] [Related]
37. Role of the progesterone receptor (PR) in the regulation of inflammatory response pathways and aromatase in the breast.
Mendelson CR; Hardy DB
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):241-9. PubMed ID: 17049843
[TBL] [Abstract][Full Text] [Related]
38. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
39. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
Kao YC; Okubo T; Sun XZ; Chen S
Anticancer Res; 1999; 19(3A):2049-56. PubMed ID: 10470147
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer.
Wang X; Docanto MM; Sasano H; ; Lo C; Simpson ER; Brown KA
Cancer Res; 2015 Feb; 75(4):645-55. PubMed ID: 25634217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
